These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12431483)

  • 1. Evidence that heterodimers exist in the fibrinogen Matsumoto II (gamma308N-->K) proband and participate in fibrin fiber formation.
    Okumura N; Terasawa F; Fujita K; Fujihara N; Tozuka M; Koh CS
    Thromb Res; 2002 Aug; 107(3-4):157-62. PubMed ID: 12431483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links.
    Park R; Ping L; Song J; Seo JY; Choi TY; Choi JR; Gorkun OV; Lord ST
    Thromb Haemost; 2013 Feb; 109(2):199-206. PubMed ID: 23224113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in electrophoretic mobility and plasmic digestion profile between four recombinant fibrinogens, gamma 308K, gamma 308I, gamma 308A, and wild type (gamma 308N).
    Okumura N; Terasawa F; Fujita K; Tozuka M; Ota H; Katsuyama T
    Electrophoresis; 2000 Jul; 21(12):2309-15. PubMed ID: 10939439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of thrombin-catalyzed fibrin polymerization and factor XIIIa-catalyzed cross-linking of fibrin among three recombinant variant fibrinogens, gamma 275C, gamma 275H, and gamma 275A.
    Hirota-Kawadobora M; Terasawa F; Suzuki T; Tozuka M; Sano K; Okumura N
    J Thromb Haemost; 2004 Aug; 2(8):1359-67. PubMed ID: 15304042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys).
    Terasawa F; Okumura N; Higuchi Y; Ishikawa S; Tozuka M; Ishida F; Kitano K; Katsuyama T
    Thromb Haemost; 1999 May; 81(5):763-6. PubMed ID: 10365751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
    Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
    Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation of mendelian properties of heterodimeric fibrinogen molecules in a heterozygotic dysfibrinogenemia, "fibrinogen Amarillo," using gprphoresis to differentiate semifibrin molecules from fibrinogen and fibrin.
    Shainoff JR; Ratnoff OD; Smejkal GB; DiBello PM; Welches WR; Lill H; Mitkevich OV; Periman P
    Thromb Res; 2001 Jan; 101(2):91-9. PubMed ID: 11342210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I).
    Mukai S; Ikeda M; Takezawa Y; Sugano M; Honda T; Okumura N
    Thromb Res; 2015 Dec; 136(6):1318-24. PubMed ID: 26573395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A functional assay suggests that heterodimers exist in two C-terminal gamma-chain dysfibrinogens: Matsumoto I and Vlissingen/Frankfurt IV.
    Hogan KA; Lord ST; Okumura N; Terasawa F; Galanakis DK; Scharrer I; Gorkun OV
    Thromb Haemost; 2000 Apr; 83(4):592-7. PubMed ID: 10780323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
    Okumura N; Furihata K; Terasawa F; Nakagoshi R; Ueno I; Katsuyama T
    Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant fibrinogen, gamma275Arg-->Cys, exhibits formation of disulfide bond with cysteine and severely impaired D:D interactions.
    Ishikawa S; Hirota-Kawadobora M; Tozuka M; Ishii K; Terasawa F; Okumura N
    J Thromb Haemost; 2004 Mar; 2(3):468-75. PubMed ID: 15009465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens.
    Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N
    Int J Lab Hematol; 2020 Apr; 42(2):190-197. PubMed ID: 31957968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.
    Lounes KC; Soria C; Valognes A; Turchini MF; Soria J; Koopman J
    Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).
    Mosesson MW; Siebenlist KR; DiOrio JP; Matsuda M; Hainfeld JF; Wall JS
    J Clin Invest; 1995 Aug; 96(2):1053-8. PubMed ID: 7635941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of fibrinogen variants at gamma387Ile shows that the side chain of gamma387 and the tertiary structure of the gammaC-terminal tail are important not only for assembly and secretion of fibrinogen but also for lateral aggregation of protofibrils and XIIIa-catalyzed gamma-gamma dimer formation.
    Kani S; Terasawa F; Yamauchi K; Tozuka M; Okumura N
    Blood; 2006 Sep; 108(6):1887-94. PubMed ID: 16705085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of recombinant Bbeta15C and Bbeta15A fibrinogens demonstrates that Bbeta15G residue plays important roles in FPB release and in lateral aggregation of protofibrils.
    Hirota-Kawadobora M; Kani S; Terasawa F; Fujihara N; Yamauchi K; Tozuka M; Okumura N
    J Thromb Haemost; 2005 May; 3(5):983-90. PubMed ID: 15869595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
    Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
    Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant γY278H Fibrinogen Showed Normal Secretion from CHO Cells, but a Corresponding Heterozygous Patient Showed Hypofibrinogenemia.
    Kamijo T; Kaido T; Yoda M; Arai S; Yamauchi K; Okumura N
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K; Terasawa F; Okumura N
    Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a dysfibrinogen, the substitution of gamma308Asn(AAT) to Lys(AAG), using coagulation tests, immunoblot analysis, and allele-specific polymerase chain reaction.
    Terasawa F; Fujita K; Tozuka M; Ota H; Katsuyama T; Okumura N
    Clin Chim Acta; 2000 May; 295(1-2):77-85. PubMed ID: 10767395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.